UTI Long Term Advantage Fund Series IV
UTI Mutual Fund · Best ELSS (Tax Saving) Mutual Funds
This is the Direct plan of UTI Long Term Advantage Fund Series IV — bought from the fund house, with no distributor commission in its expense ratio. Income is retained in the fund, so it shows up as NAV rather than as a payout.
This scheme hasn’t published a NAV since 24 Sep 2021 — it appears to have been discontinued or merged. Trailing return and risk metrics need recent pricing, so they can’t be computed; only the NAV history and lifetime drawdown are shown below.
Performance
Scorecard
Not ratedHow this is computed
Each verdict is computed from this fund's own metrics against its sub-category — the number behind it is shown, not a black-box rating. Not rated — this fund has no full year of NAV history yet. A rating needs at least a 1-year return to rank its performance against peers.
Not enough ELSS peers to rank yet
Volatility not available yet
0.7% expense vs 1.1% category avg
45% of rolling 3Y windows were positive
Strengths & concerns
Generated from this fund's own numbers against its sub-category — each point names the figure behind it.
Strengths
- Low expense ratio (0.74%) vs the ELSS average of 1.11%
Concerns
- Positive in only 45% of rolling 3-year windows
Key Metrics
Scheme Info
DefinitionsPeriod returns (<1Y, absolute — not annualized)
DefinitionsAnnualized returns (≥1Y — CAGR)
DefinitionsAdvanced metrics — risk and benchmark ratios
Not sure what a figure means? The glossary explains every metric, and the methodology shows the formulas.
Backtest this fund
What a SIP or one-time investment would have grown to over this fund’s real NAV history.
36 monthly installments of ₹10,000 into UTI Long Term Advantage Fund Series IV, valued at the latest NAV. XIRR annualizes for each installment’s timing.
Calendar-year returns
What the fund actually returned in each year, not the smoothed average.
| Year | Fund | Nifty 500 | Diff | |
|---|---|---|---|---|
| 2021part | +38.06% | — | — | |
| 2020 | +11.89% | +16.67% | -4.78% | |
| 2019 | -0.67% | +7.66% | -8.33% | |
| 2018 | -15.00% | -3.38% | -11.62% | |
| 2017part | +26.05% | — | — |
January–December, from this fund's NAV history. Absolute return, not annualised. “part” marks a year the fund didn't run end to end — its first year, the current year so far, or one it stopped reporting in; those years show no benchmark comparison.
Taxation
Taxed as equityThis is an equity-oriented fund (≥65% in Indian equities), so gains get the concessional capital-gains rates below — they do not add to your income-tax slab.
Flat, on the whole gain
On gains above ₹1.25 L per financial year
Applies to capital gains on redemption. Excludes IDCW/dividend tax, STT, surcharge and cess, and pre-2018 equity grandfathering. For research only — consult a tax advisor before filing.
Explore from here
UTI in the news
Headlines about the fund house, not this scheme in particular — highlights only; tap through to read the full story at the source.
UTI Mutual Fund sells 43,780 United Foodbrands shares
scanx.trade · 39m ago
UTI 10 year Constant Maturity Gilt Fund Regular-Growth (₹ 13.13) - NAV, Reviews & asset allocation
economictimes.com · 4h ago
UTI Mutual Fund, Bank of India MF launch new equity schemes; NFOs close on September 11
Business Today · 9h ago
India Business News: Fundraise, IBFC, Mutual Funds
Rediff MoneyWiz · 13h ago
UTI Mutual Fund launches two sectoral passive funds
Cafemutual · 14h ago
UTI MF introduces BSE India Sector Leaders Index Fund
investmentguruindia.com · 17h ago
UTI MF launches two passive funds tracking BSE India Sector Leaders Index
CNBC TV18 · 23h ago
UTI Short Term Fund Direct-IDCW Yearly (₹ 13.65) - NAV, Reviews & asset allocation
economictimes.com · 4d ago
Returns and risk are computed from NAV history and may differ slightly from other portals due to methodology (rolling vs point-to-point, dividend treatment). For research only — not investment advice.
About ELSS (tax-saving) funds
ELSS funds are equity funds that qualify for a Section 80C deduction (up to ₹1.5 lakh a year) under the old tax regime. They carry a 3-year lock-in — the shortest of any 80C option.
Frequently asked questions
What is the NAV of UTI Long Term Advantage Fund Series IV?
The last published NAV of UTI Long Term Advantage Fund Series IV was ₹16.50 per unit, on 24 Sep 2021. The scheme has not published a NAV since then — it has likely been merged, wound up or discontinued, so this figure is historical, not a current price.
What is the expense ratio of UTI Long Term Advantage Fund Series IV?
UTI Long Term Advantage Fund Series IV charges an expense ratio of 0.74% per year. This annual fee is already deducted from the NAV, so the returns you see are net of it.
What are the top holdings of UTI Long Term Advantage Fund Series IV?
UTI Long Term Advantage Fund Series IV's largest holdings are ICICI Bank Ltd (7.0%), State Bank of India (6.8%), Axis Bank Ltd (6.3%), HDFC Bank Ltd (6.2%) and Praj Industries Ltd (4.4%). Holdings are disclosed monthly and change over time.
How risky is UTI Long Term Advantage Fund Series IV?
UTI Long Term Advantage Fund Series IV is rated very high on SEBI's risk-o-meter and its worst peak-to-trough fall in our sample was -49.7%. Higher volatility means the NAV swings more; the drawdown shows how far it has fallen from a peak historically.
What is the benchmark of UTI Long Term Advantage Fund Series IV?
UTI Long Term Advantage Fund Series IV is benchmarked against the BSE 100 Total Return Index. Its alpha and beta on this page are measured against that index.
How is UTI Long Term Advantage Fund Series IV taxed?
UTI Long Term Advantage Fund Series IV is an equity-oriented fund, so its capital gains get concessional rates: short-term gains (units held under 1 year) are taxed at 20%, and long-term gains (held 1 year or more) at 12.5% above a ₹1.25 lakh per-year exemption. These rates apply on redemption and don't add to your income-tax slab.